Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alinia AI is a technology company that provides an alignment and compliance platform for generative artificial intelligence, specifically designed for highly regulated industries such as healthcare and finance. Founded in 2023, the company offers tools like the Alinia Guardrails API and Alinia RAG Guard to help enterprises evaluate, control, and optimize large language models (LLMs) to ensure they adhere to safety standards and regulatory requirements. Its platform enables real-time monitoring and auditing of AI outputs to prevent hallucinations, policy violations, and the leakage of sensitive data. By providing a safe gateway for AI deployment, Alinia AI allows organizations to scale their use of AI assistants and agents with confidence and transparency. The company is headquartered in New York and Barcelona and has secured significant venture capital funding to expand its governance infrastructure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alinia.